Short CV/Education and training

  • 1998-2004 Studies at the Faculty of Pharmacy of Coimbra University in Portugal

  • 2004-2008 PhD research, Utrecht University

  • 2008-2012 Postdoc Utrecht University and University Medical Center Utrecht

  • 2012
    Awarded VENI grant from the Netherlands Organisation for Research (NWO-STW)

  • 2015
    Awarded ERC Starting Grant to pursue research on Nanobody-targeted photodynamic therapy.

Selected publications

  • van Driel PB, Boonstra MC, Slooter MD, Heukers R, Stammes MA, Snoeks TJA, de Bruijn HS, van Diest PJ, Vahrmeijer AL, van Bergen en Henegouwen PMP, van de Velde CJH, Löwik CWGM, Robinson DJ, Oliveira S (2016): EGFR targeted nanobody-photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer, J Control Release 229, 93-105

  • Kijanka MM, van Brussel AS, van der Wall E, Mali WP, van Diest PJ, van Bergen En Henegouwen PM, Oliveira S (2016): Optical imaging of pre-invasive breast cancer with a combination of VHHs targeting CAIX and HER2 increases contrast and facilitates tumour characterization, EJNMMI Res. 6(1):14

  • Broekgaarden, M., Van Vught, R., Oliveira, Sabrina, Roovers, R. C., Van Bergen En Henegouwen, P. M P, Pieters, R. J., Van Gulik, T. M., Breukink, E. & Heger, M. (28.03.2016). Site-specific conjugation of single domain antibodies to liposomes enhances photosensitizer uptake and photodynamic therapy efficacy. Nanoscale, 8 (12), (pp. 6490-6494) (5 p.).

  • Heukers, Raimond, van Bergen en Henegouwen, P & Oliveira, Sabrina (2014). Nanobody-photosensitizer conjugates for targeted photodynamic therapy. Nanomedicine: Nanotechnology, Biology, and Medicine, 10 (7), (pp. 1441-1451).

  • Talelli, M., Oliveira, S., Rijcken, C.J.F., Pieters, E.H.E., Etrych, T., Ulbrich, K., van Nostrum, R.C., Storm, G., Hennink, W.E. & Lammers, T. (2013). Intrinsically active nanobody-modified polymeric micelles for tumor-targeted combination therapy. Biomaterials, 34 (4), (pp. 1255-60) (6 p.).

  • van Brussel, A.S.A., Adams, A.L.L., Vermeulen, J.F., Oliveira, S., van der Wall, E., Mali, W.P.T.M., van Diest, P.J. & van Bergen en Henegouwen, P.M.P. (2013). Molecular imaging with a fluorescent antibody targeting carbonic anhydrase IX can successfully detect hypoxic ductal carcinoma in situ of the breast. Breast Cancer Research and Treatment, 140 (2), (pp. 263-272) (10 p.).

  • Kijanka, M.M., Warnders, F.J., el Khattabi, M., Lub-de Hooge, M.N., van Dam, G.M., Ntziachristos, V., de Vries, L., Oliveira, S. & van Bergen en Henegouwen, P.M.P. (2013). Rapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery. European Journal of Nuclear Medicine and Molecular Imaging, 40 (11), (pp. 1718-1729) (12 p.).

  • Oliveira, Sabrina, Heukers, Raimond, Sornkom, Jirawas, Kok, Robbert J & van Bergen En Henegouwen, Paul M P (28.12.2013). Targeting tumors with nanobodies for cancer imaging and therapy. Journal of Controlled Release, 172 (3), (pp. 607-17) (11 p.). © 2013..



Complete list of publications

Selected projects

  • Nanobody-targeted photodynamic therapy

Testimonials

  1. Read what our members say about AcademiaNet.

No more excuses!

  1. Please download the brochure "No more excuses" and read more about female experts in Europe, and about AcademiaNet.

Similar profiles

  1. Prof. Dr. Amparo Acker-Palmer

    Biological and related sciences , HealthCell Biology, Cellular and Molecular Neuroscience, Vascular Biology, Tumour Biology

  2. Prof. Dr. Andrea Abele-Brehm

    Social and behavioural sciencesSocial psychology, industrial and organisational psychology

  3. Dr. Jessica Abbott

    Biological and related sciences Evolutionary biology, Evolutionary genetics

  4. Prof. Dr. Regina Elisabeth Aebi-Müller

    LawFamily law, legislation related to personal rights (esp. protection of personality rights, law of associations and foundation law), medical law, adult protection legislation, inheritance law

 

News

  1. Combining Antibodies with Light to Selectively Target Cancer

    AcademiaNet interview with Dr. Sabrina Santos Oliveira